![Ammon B. Peck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ammon B. Peck
Director Técnico/Científico/I+D en Ixion Biotechnology, Inc. .
Perfil
Ammon B.
Peck co-founded Ixion Biotechnology, Inc. in 1995 and currently serves as Chief Scientific Officer and Senior Vice President.
He is a Professor of Pathology and Laboratory Medicine at the University of Florida.
Cargos activos de Ammon B. Peck
Empresas | Cargo | Inicio |
---|---|---|
Ixion Biotechnology, Inc.
![]() Ixion Biotechnology, Inc. BiotechnologyHealth Technology Ixion Biotechnology, Inc. develops somatic cellular therapies to treat diabetes. The company was founded by Weaver H. Gaines and David C. Peck on April 4, 1994 and is headquartered in Alachua, FL. | Director Técnico/Científico/I+D | 01/01/1995 |
University of Florida | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Ixion Biotechnology, Inc.
![]() Ixion Biotechnology, Inc. BiotechnologyHealth Technology Ixion Biotechnology, Inc. develops somatic cellular therapies to treat diabetes. The company was founded by Weaver H. Gaines and David C. Peck on April 4, 1994 and is headquartered in Alachua, FL. | Health Technology |
- Bolsa de valores
- Insiders
- Ammon B. Peck